{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:51:14Z","timestamp":1769727074981,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.ejogrb.2006.09.009","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T16:21:50Z","timestamp":1161188510000},"page":"191-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nitric oxide and fibrinogen in polycystic ovary syndrome: Associations with insulin resistance and obesity"],"prefix":"10.1016","volume":"133","author":[{"given":"A.P.","family":"N\u00e1cul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.D.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"P.I. Homem","family":"de Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Spritzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2006.09.009_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/01.CIR.93.7.1331","article-title":"Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease","volume":"93","author":"Petrie","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib2","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118709","article-title":"Obesity\/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance","volume":"97","author":"Steinberg","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib4","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","author":"Birdsall","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib6","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib7","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increase endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamant-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib9","first-page":"1851","article-title":"Normal endothelial function despite insulin resistance in health women with the polycystic ovary syndrome","volume":"85","author":"Mather","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib10","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case\u2013control study","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/ije\/25.2.291","article-title":"Insulin resistance syndrome and fibrinolytic activity: the Northern Sweden MONICA study","volume":"25","author":"Lindahl","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.7326\/0003-4819-118-12-199306150-00008","article-title":"Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature","volume":"118","author":"Ernst","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib13","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1210\/jc.2002-021391","article-title":"Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity","volume":"88","author":"Dereli","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib14","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease. The Framingham study","volume":"258","author":"Kannel","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1210\/jcem-70-3-642","article-title":"Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia","volume":"70","author":"Spritzer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary Syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1097-0096(199606)24:5<243::AID-JCU3>3.0.CO;2-E","article-title":"Relevance of the determination of ovarian volume in adolescent girls with menstrual disorders","volume":"24","author":"Herter","year":"1996","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/humrep\/16.7.1340","article-title":"Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements","volume":"16","author":"Spritzer","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib22","first-page":"347","article-title":"Idiopathic Hirsutism","volume":"21","author":"Azziz","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib24","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1210\/jcem.86.11.7880","article-title":"Repeatability characteristics of simple indices of insulin resistance: implications for research applications","volume":"86","author":"Mather","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejogrb.2006.09.009_bib25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0015-0282(16)58706-8","article-title":"Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle","volume":"6","author":"Cicinelli","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/jcem-57-2-393","article-title":"Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome","volume":"57","author":"Lobo","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0039-128X(03)00093-X","article-title":"Gene expression of type 2 17\u03b2-hydroxysteroid dehydrogenase in scalp hairs of hirsute women","volume":"68","author":"Oliveira","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib29","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1210\/jcem.87.7.8634","article-title":"A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.09.009_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)56575-3","article-title":"Hemostatic and metabolic variables in women with polycystic ovary syndrome","volume":"61","author":"Dahlgren","year":"1994","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211506005136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211506005136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:17:36Z","timestamp":1759555056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211506005136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0301211506005136"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.09.009","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide and fibrinogen in polycystic ovary syndrome: Associations with insulin resistance and obesity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}